Form 4: Varex Imaging Director Guertin Receives Equity Grant

Varex Imaging Corp. Director Timothy E. Guertin was granted 12,331 Deferred Stock Units, vesting over one year.

Summary

• Timothy E. Guertin, a Director of Varex Imaging Corp. (VREX), was granted 12,331 Deferred Stock Units (DSUs) on February 12, 2026.
• Each DSU converts into one share of Varex Imaging common stock.
• The DSUs will vest 100% on the earlier of the one-year anniversary of the grant date (February 12, 2027) or the date of the next annual meeting of stockholders following the grant.
• Vested shares are scheduled for delivery to Mr. Guertin upon the earlier of the third anniversary of the grant date (February 12, 2029), a change in control of the company, or his termination of service for any reason.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive, routine event. The equity grant aligns the director's interests with shareholders, which is generally favorable, but it does not represent a new strategic initiative or significant financial development.

Positives

• The grant of 12,331 Deferred Stock Units to Director Timothy E. Guertin aligns his interests with those of shareholders, incentivizing long-term performance and commitment to the company's success.

Negatives

• No direct negative implications are apparent from this routine equity grant.

Future Outlook

This filing does not contain forward-looking statements or guidance regarding the company's future outlook.

Industry Context

StockSavvy.ai notes that equity grants to directors are a standard practice across industries, serving to align leadership incentives with shareholder value creation. Such grants are common in the medical imaging and technology sectors, where long-term strategic vision is crucial.

Comparison to Industry Standards

• The grant of Deferred Stock Units to a director is a common form of equity compensation, comparable to practices at peer companies in the medical technology sector such as Hologic, Inc. (HOLX) or Intuitive Surgical, Inc. (ISRG), which frequently use restricted stock units or similar instruments to incentivize their non-employee directors.

Related Party Transactions

• The grant of 12,331 Deferred Stock Units to Timothy E. Guertin, a Director of Varex Imaging Corp., constitutes a transaction with a related party as part of his compensation package.

Stakeholder Impact

• Shareholders: The equity grant to Director Timothy E. Guertin aligns his long-term interests with those of shareholders, potentially fostering more shareholder-centric decision-making.

Next Steps

• Vesting of 12,331 Deferred Stock Units on the earlier of February 12, 2027, or the next annual meeting of stockholders.
• Delivery of vested shares on the earlier of February 12, 2029, a change in control, or termination of service.

Key Dates

Recommendation

This Form 4 filing details a routine equity grant to a director, which is a standard compensation practice. It does not present new information that would significantly alter the investment thesis for Varex Imaging Corp., thus a 'hold' recommendation is appropriate.

Keywords

Varex Imaging, VREX, Timothy Guertin, Director, Deferred Stock Units, DSU, Equity Grant, Compensation, Insider Transaction, Form 4